PsyAtlas
Back to the directory

Anodyne Healthcare (Melbourne)

Melbourne, Victoria, Australia, part of Anodyne Healthcare

Spravato
Verified 2026-08-05

Inpatient and outpatient ketamine therapy co-located with Brunswick Private Hospital, with esketamine (Spravato) among listed treatments. Treats depression, PTSD, suicidality and chronic pain conditions including neuropathic pain, fibromyalgia and CRPS.

Treatments offered

  • Spravato (esketamine)

    The one psychedelic-adjacent medicine the FDA has approved for treatment-resistant depression, and for depression with acute suicidal thinking. Given at a certified center and often covered by insurance after prior authorization.

Pricing

This provider does not publish prices. Contact them directly for a quote, and ask what a full course costs rather than a single session.

Insurance and reimbursement

Spravato is billed through insurance at certified centers, usually after prior authorization. Confirm network status with this provider.

  • Spravato is FDA-approved, so most commercial plans plus Medicare and Medicaid cover it after prior authorization.
  • The clinic submits the prior authorization; approval usually requires documented failure of two or more oral antidepressants.
  • You pay your plan's normal specialist copay per visit, and the manufacturer's copay program can reduce that further for commercial plans.
How insurance works for this treatment

Who can apply

  • Most clinics require a GP or psychiatrist referral.
  • Usually offered after standard antidepressants have been trialled.
Full eligibility guide

Legal basis: Legal, prescribed off-label, Australia

Australian clinics offer ketamine and esketamine for treatment-resistant depression under specialist prescription, in line with TGA and state regulations.

More on legality here

Sources

Where this listing's information came from. Always confirm details with the provider before booking.

More in Australia